Weill Cornell Medicine researchers have secured funding to create an on-demand male contraceptive pill that can inhibit sperm movement for six to eight hours. This innovative study prioritizes safety and efficiency, with plans for human trials in the near future. If successful, it could redefine family planning dynamics for couples, although it’s important to remember that this pill won’t prevent sexually transmitted infections, underscoring the continued need for condoms.
